Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT06271616
What this trial is testing

Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm
Mayo Clinic 2
Testing effectiveness (Phase 2)UnknownNCT06141304
What this trial is testing

Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT

Who this might be right for
Relapsed Adult ALLRelapsed Adult AML
The First Hospital of Jilin University 28
Large-scale testing (Phase 3)Not Yet RecruitingNCT07157514
What this trial is testing

Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML

Who this might be right for
Acute LeukemiaMyeloid LeukemiaAcute Myelogenous Leukemia+8 more
Actinium Pharmaceuticals 306
Not applicableEnded earlyNCT00008216
What this trial is testing

Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Adult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more
Columbia University 48
Not applicableStudy completedNCT00427661
What this trial is testing

A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen

Who this might be right for
Sickle Cell DiseaseThalassemiaHemoglobinopathies
University of Pittsburgh 8
Testing effectiveness (Phase 2)Ended earlyNCT02350777
What this trial is testing

T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell TransplantPoor Marrow Graft Function
Memorial Sloan Kettering Cancer Center 4
Early research (Phase 1)Ended earlyNCT00325741
What this trial is testing

Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Stanford University 1
Not applicableLooking for participantsNCT07763054
What this trial is testing

Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome+6 more
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine 30
Not applicableLooking for participantsNCT07588594
What this trial is testing

Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia

Who this might be right for
Chronic Myelomonocytic Leukemia (CMML)
Peking University People's Hospital 31
Large-scale testing (Phase 3)Study completedNCT00750737
What this trial is testing

Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)

Who this might be right for
Invasive Fungal InfectionsHematologic Malignancies
M.D. Anderson Cancer Center 46
Testing effectiveness (Phase 2)Ended earlyNCT01773395
What this trial is testing

GVAX vs. Placebo for MDS/AML After Allo HSCT

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Dana-Farber Cancer Institute 123
Testing effectiveness (Phase 2)Ended earlyNCT01135537
What this trial is testing

Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants

Who this might be right for
MalignancyMetabolic DiseaseGenetic Disorder
The Hospital for Sick Children 30
Not applicableStudy completedNCT01219972
What this trial is testing

Pulmonary Complications of Allografts

Who this might be right for
Pulmonary Complications
Assistance Publique - Hôpitaux de Paris 245
Testing effectiveness (Phase 2)Looking for participantsNCT06926595
What this trial is testing

Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention

Who this might be right for
Graft-versus-Host Disease (GVHD)Hematologic MalignanciesAllogeneic Stem Cell Transplantation
Milton S. Hershey Medical Center 41
Early research (Phase 1)Study completedNCT00809250
What this trial is testing

Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome-Refractory Anemia With Excess Blasts
Dana-Farber Cancer Institute 33
Testing effectiveness (Phase 2)WithdrawnNCT04127721
What this trial is testing

Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation

Who this might be right for
Allogeneic Stem Cell Transplant RecipientHematologic and Lymphocytic DisorderHematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center
Not applicableStudy completedNCT01206309
What this trial is testing

Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft vs Host DiseaseCutaneous SclerosisBronchiolitis Obliterans
Fred Hutchinson Cancer Center 911
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06954987
What this trial is testing

Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 244
Very early researchNot Yet RecruitingNCT07476014
What this trial is testing

Early Clinical Study on the Use of Donor-derived EBV-specific T Cells for the Prevention of EBV Infection After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Prevention of EBV Infection After Allogeneic Hematopoietic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China 18
Not applicableNot Yet RecruitingNCT07679100
What this trial is testing

BANDICOOT: An Adaptive Platform Trial to Improve Health Outcomes After Paediatric Stem Cell Transplant

Who this might be right for
Haematopoietic Stem Cell Transplant, Allogeneic
Murdoch Childrens Research Institute 10,000
Next Page